Radiation-Induced miR-208a Predicts Cancer Recurrence Risk
- Okay, here's a breakdown of teh provided citations, formatted for clarity.
- (2020).Radiotherapy treatment for lung cancer: current status and future directions.
- PB01 suppresses radio-resistance by regulating ATR signaling in human non-small-cell lung cancer cells.
Okay, here’s a breakdown of teh provided citations, formatted for clarity. I’ve included the authors, year, title, journal, and DOI where available. I’ve also noted any apparent errors or inconsistencies.
1. SK, hau E. (2020).Radiotherapy treatment for lung cancer: current status and future directions. Respirology, 25(Suppl 2(S2)), 61-71. doi:10.1111/resp.13870
2.Kim TW, Hong DW, Hong SH. (2021). PB01 suppresses radio-resistance by regulating ATR signaling in human non-small-cell lung cancer cells. Sci Rep, 11(1), 12093. doi:10.1038/s41598-021-91716-z
3. Lee YS, Dutta A. (2009). MicroRNAs in cancer. annu Rev Pathol, 4*(1), 199-227. doi:10.1146/annurev.pathol.4.110807.092222
4. Huscent BM, HJ, salihi A, Sabir DK, M, Ghafoard S. (2021). MicroRNA: a Sign up West form a progrant dincession. *Biomed Pharmacother, 138, 111528. doi:10.1016/j.biopha.2021.111528
* Note: The title appears to have significant errors (“Sign up West form a progrant dincession”). This is likely a transcription error.
5. Volinia S, Calin GA, Liu CG, et al. (2006). A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A, 103(7), 2257-2261. doi:10.1073/pnas.0510565103
6. Tang Y, Cui Y, Li Z, et al. (2016). Radiation-induced miR-208a increases the proliferation and radioresistance by targeting p21 in human lung cancer cells. J exp Clin Cancer Res, 35(1), 7. doi:10.1186/s13046-016-0285-3.Erratum in: J Exp Clin Cancer Res. 2016 Jan 28;35:20. doi: 10.1186/s13046-016-0299-x.
* Note: This citation includes a note about an Erratum (correction) published in the same journal.
7. Zhang L, Hu J, Li J, Yang Q, Hao M, Bu L. (2019). Long noncoding RNA LINC-PINT inhibits non-small cell lung cancer progression through sponging miR-218-5p/PDCD4. Artif Cells Nanomed Biotechnol, 47(1), 1595-1602. doi:10.1080/21691401.2019.1605371
8. Liu L, Wang W, Gao S, Wang X. (2019). MicroRNA‑208a directly targets Src kinase signaling inhibitor 1 to facilitate cell proliferation and invasion in non‑small cell lung cancer. Mole with rep, 20(4), 3140-3148. doi: 10.3892/mmr.2019.10542
* Note: The journal title appears to be a typo (“Mole with rep”). It’s likely meant to be molecular Medicine Reports.
9. Zheng Q, Ji W, Sun R, Dai K. (2024). Prognostic value of blood GRHL2 in patients with non-small-cell lung cancer after radiotherapy and chemotherapy. Biomarkers with, 18(13-14), 611-61